Fulzerasib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Fulzerasib, covering 2025-04-20 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC [Phase 2]